# PLPP2

## Overview
Phospholipid phosphatase 2 (PLPP2) is a gene that encodes an integral membrane glycoprotein involved in lipid metabolism. The protein product, also known as phospholipid phosphatase 2, is a member of the phospholipid phosphatase family and plays a critical role in catalyzing the dephosphorylation of phosphatidic acid to diacylglycerol. This enzymatic activity is essential for lipid signaling and membrane dynamics, influencing processes such as cell proliferation, survival, and differentiation. As an integral membrane protein, phospholipid phosphatase 2 is active in the cell membrane, where it contributes to the formation of lipid rafts—dynamic microdomains crucial for signal transduction and cell cycle regulation (Wang2023Transcriptomic). The gene and its protein product have been implicated in various pathological conditions, including cancer, where alterations in expression levels are associated with disease progression and prognosis (Benesch2023Decreased; Sheng2024PLPP2).

## Function
PLPP2 (phospholipid phosphatase 2) is an enzyme involved in lipid metabolism, specifically catalyzing the dephosphorylation of phosphatidic acid to diacylglycerol. This enzymatic activity is crucial for lipid signaling and membrane dynamics, playing a significant role in regulating cell proliferation, survival, and differentiation. PLPP2 is an integral membrane glycoprotein, active in the cell membrane, where it participates in the formation of lipid rafts. These lipid rafts are small, dynamic domains within the cell membrane that are essential for signal transduction and cell cycle regulation (Wang2023Transcriptomic).

In healthy human cells, PLPP2 is involved in normal cellular processes related to lipid signaling and membrane dynamics. It is part of the phospholipid phosphatase family, which is known for hydrolyzing various lipid phosphates, thereby influencing membrane-associated functional subsets and lipid composition (Wang2023Transcriptomic). While the specific functions of PLPP2 in healthy cells are not extensively detailed, its role in lipid metabolism suggests it contributes to maintaining cellular homeostasis and membrane integrity. The enzyme's activity in lipid raft formation indicates its involvement in organizing membrane microdomains that facilitate cellular communication and signaling pathways (Wang2023Transcriptomic).

## Clinical Significance
PLPP2 (phospholipid phosphatase 2) is implicated in various cancers due to alterations in its expression levels. In lung adenocarcinoma (LUAD), elevated PLPP2 levels are associated with poor prognosis and are considered an independent prognostic risk factor. PLPP2 promotes cancer progression by enhancing lipid raft formation, which is crucial for cell proliferation and tumor growth (Wang2023Transcriptomic). In breast cancer, PLPP2 expression is significantly higher in triple-negative breast cancer (TNBC) and correlates with increased tumor grades and cell proliferation. High PLPP2 levels are linked to reduced disease-free survival and overall survival, suggesting its role in tumor progression and immune system evasion (Benesch2023Decreased; Tang2022Lipid).

In pancreatic cancer, PLPP2 is associated with poor survival and prognosis. It contributes to an immune-suppressive microenvironment and is linked to resistance to immune checkpoint inhibitors (Sheng2024PLPP2). PLPP2 is also upregulated in other cancers, such as colon, liver, and prostate cancer, where it is involved in tumor growth by modulating cell-cycle progression (Wang2023Transcriptomic). These findings suggest that PLPP2 plays a significant role in cancer progression and may serve as a potential target for therapeutic intervention.

## Interactions
PLPP2, or phospholipid phosphatase 2, is involved in various interactions that influence cellular processes. In the context of Alzheimer's disease, PLPP2 interacts with immune-related genes such as PPARA and GPI. PPARA shows a positive correlation with PLPP2, while GPI exhibits a negative correlation, suggesting a role in modulating immune responses (Zeng2023Identification).

In pancreatic cancer, PLPP2 is implicated in the tumor immune microenvironment. It affects CD8+ T cell infiltration and function, with reduced PLPP2 expression leading to increased CD8+ T cell activity and decreased PD-1 expression, enhancing sensitivity to anti-PD-1 therapy (Sheng2024PLPP2). This indicates that PLPP2 may interact with immune signaling pathways, influencing the efficacy of immunotherapy.

In early-stage lung adenocarcinoma, PLPP2 is associated with lipid raft formation, which is crucial for cell proliferation. It interacts with lipid raft-associated proteins such as caveolin-1 and flotillin-1, affecting their localization and function on the cell membrane. This interaction promotes tumor growth and survival by enhancing lipid raft-mediated signaling pathways (Wang2023Transcriptomic). These interactions highlight PLPP2's role in modulating membrane dynamics and cellular signaling in cancer progression.


## References


[1. (Wang2023Transcriptomic) Yibei Wang, Ziwei Miao, Xiaoxue Qin, Yi Yang, Si Wu, Qi Miao, Beibei Li, Mingyu Zhang, Pengfei Wu, Yun Han, and Bo Li. Transcriptomic landscape based on annotated clinical features reveals plpp2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma. Journal of Experimental &amp; Clinical Cancer Research, November 2023. URL: http://dx.doi.org/10.1186/s13046-023-02877-w, doi:10.1186/s13046-023-02877-w. This article has 1 citations.](https://doi.org/10.1186/s13046-023-02877-w)

[2. (Zeng2023Identification) Youjie Zeng, Si Cao, Nannan Li, Juan Tang, and Guoxin Lin. Identification of key lipid metabolism-related genes in alzheimer’s disease. Lipids in Health and Disease, September 2023. URL: http://dx.doi.org/10.1186/s12944-023-01918-9, doi:10.1186/s12944-023-01918-9. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12944-023-01918-9)

[3. (Benesch2023Decreased) Matthew G. K. Benesch, Rongrong Wu, Xiaoyun Tang, David N. Brindley, Takashi Ishikawa, and Kazuaki Takabe. Decreased lipid phosphate phosphatase 1/3 and increased lipid phosphate phosphatase 2 expression in the human breast cancer tumor microenvironment promotes tumor progression and immune system evasion. Cancers, 15(8):2299, April 2023. URL: http://dx.doi.org/10.3390/cancers15082299, doi:10.3390/cancers15082299. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15082299)

[4. (Tang2022Lipid) Xiaoyun Tang, Christopher R. Cromwell, Rongzong Liu, Roseline Godbout, Basil P. Hubbard, Todd P.W. McMullen, and David N. Brindley. Lipid phosphate phosphatase-2 promotes tumor growth through increased c-myc expression. Theranostics, 12(13):5675–5690, 2022. URL: http://dx.doi.org/10.7150/thno.66230, doi:10.7150/thno.66230. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7150/thno.66230)

5. (Sheng2024PLPP2) PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic cancer. This article has 0 citations.